Lanreotide 60Mg Solution for Injection: Clinical Trials

1 trial of Lanreotide 60Mg Solution for Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow Lanreotide 60Mg Solution for Injection: new trials by email Literature Review of Lanreotide 60Mg Solution for Injection trials Research Report on Lanreotide 60Mg Solution for Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma
Gamma knife radiosurgery, Lanreotide 60Mg Solution for Injection - Acromegaly Due to Pituitary Adenoma
Phase 3UnknownSamsung Medical Center902018-03-012018-03-01

Conditions studied

Acromegaly (1)  ·  Growth Hormone-Secreting Pituitary Adenoma (1)  ·  Pituitary Neoplasms (1)

Sponsors

Samsung Medical Center (1)

Countries

South Korea (1)